Delivery Order SPE2DX22D0010-SPE2D826FAH90

This delivery order, awarded October 14, 2025, represents a $81,358.70 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, with an ultimate completion date of October 15, 2025, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. As a non-set-aside award, this delivery order was competitively awarded and reflects the contractor's ongoing role as a critical pharmaceutical distributor for federal medical procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania.

AmerisourceBergen Drug Corp is a major pharmaceutical and healthcare solutions provider that supplies a comprehensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's federal contract awards demonstrate capability across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. Through its substantial IDC with DLA Troop Support Medical, AmerisourceBergen serves as a global pharmaceutical support vehicle enabling distribution to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a key vendor in the Defense Logistics Agency's pharmaceutical supply chain infrastructure.